215 related articles for article (PubMed ID: 30901686)
1. Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo C. difficile infection model.
Tague AJ; Putsathit P; Hutton ML; Hammer KA; Wales SM; Knight DR; Riley TV; Lyras D; Keller PA; Pyne SG
Eur J Med Chem; 2019 May; 170():203-224. PubMed ID: 30901686
[TBL] [Abstract][Full Text] [Related]
2. Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles: synthesis, antibacterial evaluation and preliminary mechanism of action studies.
Tague AJ; Putsathit P; Hammer KA; Wales SM; Knight DR; Riley TV; Keller PA; Pyne SG
Eur J Med Chem; 2019 Apr; 168():386-404. PubMed ID: 30831407
[TBL] [Abstract][Full Text] [Related]
3. Cationic Peptidomimetic Amphiphiles Having a
Mahadari MK; Jennepalli S; Tague AJ; Putsathit P; Hutton ML; Hammer KA; Knight DR; Riley TV; Lyras D; Keller PA; Pyne SG
Antibiotics (Basel); 2021 Jul; 10(8):. PubMed ID: 34438963
[No Abstract] [Full Text] [Related]
4. Binaphthyl-1,2,3-triazole peptidomimetics with activity against Clostridium difficile and other pathogenic bacteria.
Wales SM; Hammer KA; King AM; Tague AJ; Lyras D; Riley TV; Keller PA; Pyne SG
Org Biomol Chem; 2015 May; 13(20):5743-56. PubMed ID: 25901416
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of cell selective α/β-diastereomeric peptidomimetic with potent in vivo antibacterial activity against methicillin resistant S. Aureus.
Dewangan RP; Bisht GS; Singh VP; Yar MS; Pasha S
Bioorg Chem; 2018 Feb; 76():538-547. PubMed ID: 29310083
[TBL] [Abstract][Full Text] [Related]
6. Bis-Cyclic Guanidines as a Novel Class of Compounds Potent against Clostridium difficile.
Li C; Teng P; Peng Z; Sang P; Sun X; Cai J
ChemMedChem; 2018 Jul; 13(14):1414-1420. PubMed ID: 29768720
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of short amphiphilic cationic peptidomimetics based on biphenyl backbone as antibacterial agents.
Kuppusamy R; Yasir M; Berry T; Cranfield CG; Nizalapur S; Yee E; Kimyon O; Taunk A; Ho KKK; Cornell B; Manefield M; Willcox M; Black DS; Kumar N
Eur J Med Chem; 2018 Jan; 143():1702-1722. PubMed ID: 29133052
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial and Solubility Optimization of Thiomuracin A.
LaMarche MJ; Leeds JA; Brewer J; Dean K; Ding J; Dzink-Fox J; Gamber G; Jain A; Kerrigan R; Krastel P; Lee K; Lombardo F; McKenney D; Neckermann G; Osborne C; Palestrant D; Patane MA; Rann EM; Robinson Z; Schmitt E; Stams T; Tiamfook S; Yu D; Whitehead L
J Med Chem; 2016 Jul; 59(14):6920-8. PubMed ID: 27355833
[TBL] [Abstract][Full Text] [Related]
9. [Antimicrobial profile and clinical evidence of fidaxomicin (Dafclir
Takeda S; Miki T
Nihon Yakurigaku Zasshi; 2019; 154(4):217-229. PubMed ID: 31597902
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimicrobial evaluation of cationic low molecular weight amphipathic 1,2,3-triazoles.
Bakka TA; Strøm MB; Andersen JH; Gautun OR
Bioorg Med Chem Lett; 2017 Mar; 27(5):1119-1123. PubMed ID: 28189422
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of cationic norbornanes as peptidomimetic antibacterial agents.
Hickey SM; Ashton TD; Khosa SK; Robson RN; White JM; Li J; Nation RL; Yu HY; Elliott AG; Butler MS; Huang JX; Cooper MA; Pfeffer FM
Org Biomol Chem; 2015 Jun; 13(22):6225-41. PubMed ID: 25958967
[TBL] [Abstract][Full Text] [Related]
12. Targeting methionyl tRNA synthetase: design, synthesis and antibacterial activity against Clostridium difficile of novel 3-biaryl-N-benzylpropan-1-amine derivatives.
Eissa AG; Blaxland JA; Williams RO; Metwally KA; El-Adl SM; Lashine el-SM; Baillie LW; Simons C
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1694-7. PubMed ID: 26899668
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of DS-2969b and comparator antimicrobial agents against Clostridioides (Clostridium) difficile, methicillin-resistant Staphylococcus aureus, and other anaerobic bacteria.
Tyrrell KL; Citron DM; Merriam CV; Leoncio E; Goldstein EJC
Anaerobe; 2018 Dec; 54():39-41. PubMed ID: 30096588
[TBL] [Abstract][Full Text] [Related]
14. Salicylanilide Analog Minimizes Relapse of
Blake S; Thanissery R; Rivera AJ; Hixon MS; Lin M; Theriot CM; Janda KD
J Med Chem; 2020 Jul; 63(13):6898-6908. PubMed ID: 32482070
[No Abstract] [Full Text] [Related]
15. Facilely accessible quinoline derivatives as potent antibacterial agents.
Teng P; Li C; Peng Z; Anne Marie V; Nimmagadda A; Su M; Li Y; Sun X; Cai J
Bioorg Med Chem; 2018 Jul; 26(12):3573-3579. PubMed ID: 29858158
[TBL] [Abstract][Full Text] [Related]
16. Clostridioides (Clostridium) difficile infection: current and alternative therapeutic strategies.
Gil F; Calderón IL; Fuentes JA; Paredes-Sabja D
Future Microbiol; 2018 Mar; 13():469-482. PubMed ID: 29464969
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial bioactivities of cationic deacetyl linezolid amphiphiles.
Bai PY; Qin SS; Chu WC; Yang Y; Cui DY; Hua YG; Yang QQ; Zhang E
Eur J Med Chem; 2018 Jul; 155():925-945. PubMed ID: 29966917
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid conjugated pyridinium cationic amphiphiles as antibacterial agents and self-assembling nano carriers.
Walvekar P; Gannimani R; Rambharose S; Mocktar C; Govender T
Chem Phys Lipids; 2018 Aug; 214():1-10. PubMed ID: 29730266
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of short cationic antimicrobial peptidomimetics containing arginine analogues.
Baldassarre L; Pinnen F; Cornacchia C; Fornasari E; Cellini L; Baffoni M; Cacciatore I
J Pept Sci; 2012 Sep; 18(9):567-78. PubMed ID: 22807132
[TBL] [Abstract][Full Text] [Related]
20. Metronidazole-triazole conjugates: activity against Clostridium difficile and parasites.
Jarrad AM; Karoli T; Debnath A; Tay CY; Huang JX; Kaeslin G; Elliott AG; Miyamoto Y; Ramu S; Kavanagh AM; Zuegg J; Eckmann L; Blaskovich MA; Cooper MA
Eur J Med Chem; 2015 Aug; 101():96-102. PubMed ID: 26117821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
